Menu Close

Trending

Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise
GSK gets June 2023 FDA decision date for momelotinib
End of the line for Sanofi’s SERD amcenestrant as it fails first-line trial
Key Presentations at the Medical Devices & IVD Conference Released
Respiratory Monitoring & AI Technologies

Medical Affairs Spotlight

Spotlight Focus on Future of Medical Affairs

iStock-901934384-16x9

Medical Affairs Spotlight/ Medical Affairs Spotlight - main/ Sales and Marketing/ Sales and Marketing/ Views & Analysis/ Views and analysis

Cementing the Value of Medical Affairs

, , , 0 Comment

A number of trends including tougher regulatory controls, increased transparency expectations, an increasingly vocal patient and greater requirements

X
Cementing the Value of Medical Affairs
https://pharmaphorum.com/views-analysis-sales-marketing/cementing-value-medical-affairs/
lightbulb_image

Medical Affairs Spotlight/ Medical Affairs Spotlight - partner/ Partner Content/ Partner content/ Press releases/ Sales and Marketing

“The important thing is to not stop questioning.” (Albert Einstein)

, , , 0 Comment

Intuition and experience – the ideal combination for finding a solution to an issue… or is it? What

X
“The important thing is to not stop questioning.” (Albert Einstein)
https://pharmaphorum.com/partner-content-sales-marketing/important-thing-not-stop-questioning-albert-einstein/
Moving to the next stage in medical affairs: an analysis in melanoma immunotherapy

Cancer/ Medical Affairs Spotlight - main/ Pharma Market Access/ Sales and Marketing/ Views and analysis

Moving to the next stage in medical affairs: an analysis in melanoma immunotherapy

0 Comment

With an ever-growing array of new scientific data, medical affairs is evolving into its 2.0 iteration. Now, the

X
Moving to the next stage in medical affairs: an analysis in melanoma immunotherapy
https://pharmaphorum.com/views-and-analysis/moving-next-stage-medical-affairs-analysis-in-melanoma-immunotherapy/

Login

CONTINUE TO SITE >
X
Close in 10 seconds